4 active not recruiting, 4 completed. 8 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 8 | Active not recruiting 4, Completed 4 |
Follow Synovitis: new trials by email Literature Review of Synovitis trials Research Report on Synovitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Etoricoxib/Betamethasone Combination in Acute Bursitis, Tendinitis and Synovitis Fixed Dose Etoricoxib + Betamethasone, Monotherapy Etoricoxib - Bursitis, Tendinitis | Phase 3 | Completed | Laboratorios Silanes S.A. de C.V. | 89 | 2025-05-14 | 2026-01-08 |
| Study of Emactuzumab for Tenosynovial Giant Cell Tumor (TGCT) Emactuzumab, Placebo - TGCT | Phase 3 | Active not recruiting | SynOx Therapeutics Limited | 128 | 2024-10-09 | 2026-07-29 |
| Study of Pimicotinib (ABSK021) for Tenosynovial Giant Cell Tumor (MANEUVER) Pimicotinib(ABSK021), Placebo - Tenosynovial Giant Cell Tumor, Pigmented Villonodular Synovitis | Phase 3 | Active not recruiting | Abbisko Therapeutics Co, Ltd | 94 | 2023-04-27 | 2026-05-04 |
| Study of Vimseltinib for Tenosynovial Giant Cell Tumor Vimseltinib, Placebo - Tenosynovial Giant Cell Tumor, Pigmented Villonodular Synovitis | Phase 3 | Active not recruiting | Deciphera Pharmaceuticals, LLC | 123 | 2021-10-14 | 2026-03-20 |
| A Study of the Efficacy and Safety of Pexidartinib in Adult Subjects With TGCT Pexidartinib - Tenosynovial Giant Cell Tumor | Phase 3 | Active not recruiting | Daiichi Sankyo Co., Ltd. | 40 | 2020-09-25 | 2026-06-26 |
| Study of Power Doppler Ultrasound (PDUS) to Measure Response of Secukinumab Treatment in Patients With Active Psoriatic Arthritis (PsA) AIN457 (secukinumab), Placebo - Psoriatic Arthritis | Phase 3 | Completed | Novartis Pharmaceuticals | 166 | 2016-08-22 | 2021-12-07 |
| Phase 3 Study of Pexidartinib for Pigmented Villonodular Synovitis (PVNS) or Giant Cell Tumor of the Tendon Sheath (GCT-TS) Pexidartinib, Placebo - Pigmented Villonodular Synovitis, Giant Cell Tumors of the Tendon Sheath | Phase 3 | Completed | Daiichi Sankyo | 120 | 2015-05-11 | 2022-05-11 |
| Effect of Chondroitin Sulphate on Synovial Inflammation in Patients With Osteoarthritis of the Knee Chondroitin sulphate (Condrosan), Placebo - Synovitis, Osteoarthritis | Phase 3 | Completed | Bioiberica | 70 | 2008-02-01 | 2011-12-19 |
Giant Cell Tumor of Tendon Sheath (4) · Synovitis, Pigmented Villonodular (4) · Arthritis (1) · Arthritis, Psoriatic (1) · Bursitis (1) · Joint Diseases (1) · Osteoarthritis (1) · Osteoarthritis, Knee (1) · Tendinopathy (1)
Musculoskeletal Diseases (8) · Joint Diseases (7) · Muscular Diseases (6) · Giant Cell Tumors (5) · Neoplasms (5) · Neoplasms by Histologic Type (5) · Neoplasms, Connective Tissue (5) · Neoplasms, Connective and Soft Tissue (5) · Tendinopathy (5) · Arthritis (1) · Bone Diseases (1) · Giant Cell Tumor of Tendon Sheath (1) · Psoriasis (1) · Rheumatic Diseases (1)
pexidartinib (2) · Betamethasone (1) · Chondroitin (1) · Etoricoxib (1) · emactuzumab (1) · secukinumab (1)
Abbisko Therapeutics Co, Ltd (1) · Bioiberica (1) · Daiichi Sankyo (1) · Daiichi Sankyo Co., Ltd. (1) · Deciphera Pharmaceuticals, LLC (1) · Laboratorios Silanes S.A. de C.V. (1) · Novartis Pharmaceuticals (1) · SynOx Therapeutics Limited (1)
Canada (6) · Italy (5) · Netherlands (5) · Spain (5) · United States (5) · France (4) · United Kingdom (4) · Germany (3) · Poland (3) · Australia (2) · Belgium (2) · China (2) · Hungary (2) · Mexico (2) · Norway (2)
Jean Y Blay, Prof, MD (1) · Jean-Pierre Pelletier, Prof., Dr. (1) · Johanne Martel-Pelletier, Prof., Dr. (1) · Juan Luis Torres Mendez, MD (1) · Marco Antonio Cordova Martinez, MD (1) · Pedro Abraham Garza Alvarez, MD (1) · Yazmin Adriana Guerra Lopez, MD (1)
PMID 21367761, PMID 27041409, PMID 31229240, PMID 32755241, PMID 33289960, PMID 34528079, PMID 36001000, PMID 37593881, PMID 38843860, PMID 39287124, PMID 40841499, PMID 41612350, PMID 41796601, PMID 42132251, PMID 42473802, PMID 42872549
2014 (1), 2015 (1)